Serum level of nerve growth factor is a potential biomarker of conversion to bipolar disorder in women with major depressive disorder.

Fernanda Pedrotti MoreiraTaiane C CardosoThaíse C MondinCarolina D WienerLuciano D de Mattos SouzaJean P OsesKaren Jansen Ricardo Azevedo da Silva

Published in: Psychiatry and clinical neurosciences (2019)

Our results suggest that NGF might be a useful biomarker associated with early detection of conversion to BD, helping clinicians in the clinical diagnosis.

Keyphrases

growth factor
major depressive disorder
bipolar disorder
palliative care
peripheral nerve